gatifloxacin has been researched along with Chlamydia pneumoniae Infections in 9 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muhlestein, JB | 1 |
| Pokrovskaia, EV | 1 |
| Conti, CR | 1 |
| Cannon, CP | 2 |
| Braunwald, E | 2 |
| McCabe, CH | 2 |
| Grayston, JT | 1 |
| Muhlestein, B | 1 |
| Giugliano, RP | 1 |
| Cairns, R | 1 |
| Skene, AM | 1 |
| Anderson, JL | 1 |
| Mitchell, WM | 1 |
| Stratton, CW | 1 |
| Frothingham, R | 1 |
| Taylor-Robinson, D | 1 |
| Boman, J | 1 |
| Belder, R | 1 |
| Breen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000617] | Phase 3 | 0 participants | Interventional | 1998-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gatifloxacin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
Antibiotic treatment of atherosclerosis.
Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular D | 2003 |
1 trial available for gatifloxacin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
Topics: Aged; Angina, Unstable; Anti-Bacterial Agents; Cardiovascular Diseases; Chlamydophila Infections; Ch | 2005 |
7 other studies available for gatifloxacin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
[Final confirmation of inefficiency of antibiotics in secondary prevention of coronary heart disease. Results of PROVE IT (gatifloxacin trial) and ACES].
Topics: Anti-Bacterial Agents; Azithromycin; C-Reactive Protein; Chlamydophila Infections; Chlamydophila pne | 2004 |
Antibiotics for coronary disease: it's time to move on.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Chlamydophila Infections; Chlamydophila p | 2004 |
Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?
Topics: Angina, Unstable; Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Chlamydophila Infect | 2005 |
Chlamydia pneumoniae and acute coronary syndrome.
Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; Chlamydophila Infections; Chlamydoph | 2005 |
Chlamydia pneumoniae and acute coronary syndrome.
Topics: Anti-Bacterial Agents; Cardiovascular Diseases; Cause of Death; Chlamydophila Infections; Chlamydoph | 2005 |
The failure of antibiotics to prevent heart attacks.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Ar | 2005 |
Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial.
Topics: Angina, Unstable; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Chlamydophila Infec | 2002 |